CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited) - USD ($) $ in Thousands	9 Months Ended
	Oct. 29, 2016	Oct. 31, 2015
Cash flows from operating activities:
Net loss	$ (44,065)	$ (3,470)
Adjustments to reconcile net loss to net cash flows from operating activities:
Depreciation and amortization	35,326	33,787
Net gain on asset disposition	(391)	(2,657)
Provision for store closures and asset impairment	24,114	315
Stock-based compensation	2,209	1,721
Provision (benefit) for uncollectible receivables	(1,041)	403
LIFO reserve increase	3,178	3,557
Deferred income tax benefit	(10,038)	(3,826)
Income tax benefit (charge) upon exercise of stock options	41	(216)
Amortization of debt issuance costs	79	128
(Increase) decrease in operating assets:
Trade and non-trade receivables	4,481	(5,811)
Insurance receivables	(147)	(236)
Inventories	(45,282)	(55,789)
Other assets	(675)	793
Increase (decrease) in operating liabilities:
Accounts payable and accrued expenses	45,158	96,562
Income taxes payable	183	9,206
Other noncurrent liabilities	(901)	2,394
Net cash provided by operating activities	12,229	76,861
Cash flows provided by (used in) investing activities:
Capital expenditures	(20,315)	(15,561)
Proceeds from asset dispositions	1,868	3,401
Insurance recoveries for replacement assets	316
Asset acquisition, net (primarily intangibles)	(11,934)	(12,720)
Acquisition of Reeves-Sain Drug Store, Inc., net of cash		(42,750)
Net cash used in investing activities	(30,065)	(67,630)
Cash flows provided by (used in) financing activities:
Payments of indebtedness and capital lease obligations	(606)	(532)
Proceeds from revolving line of credit	689,853	628,617
Payments on revolving line of credit	(665,180)	(632,461)
Debt issuance costs		(525)
Excess tax charges from stock-based compensation	(41)	216
Proceeds from exercise of stock options and employee stock purchase plan	305	2,343
Cash dividends paid	(6,720)	(6,686)
Net cash provided by (used in) financing activities	17,611	(9,028)
Increase (decrease) in cash and cash equivalents	(225)	203
Cash and cash equivalents:
Beginning of year	5,917	6,440
End of period	5,692	6,643
Supplemental disclosures of cash flow information:
Interest paid	1,685	1,063
Income taxes refunded	(1,693)	(9,070)
Non-cash investing and financial activities:
Acquisition related note payable, see Note 11 - Business Combinations		$ 13,000